MedTrace Logo

Compex SP8.0 - Symptomatic Treatment of Musculoskeletal Pain

NCT06717789 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2025-02-06

No results posted yet for this study

Summary

This post-market clinical study of the SP8.0 Compex device aims to comprehensively assess the safety and performance of the device when used in accordance with the approved Instructions for Use. The results of this study will also support the clinical evaluation of the next-generation wireless product currently under development.

The Compex Consumer devices contain different programs, such as conditioning, fitness, recovery, massage, rehabilitation, and pain management.

This study will utilize the Compex SP 8.0 pain management programs, with the aim of assessing the effectiveness of the treatment provided by the device in managing pain through different physiological mechanisms.

Conditions

Interventions

DEVICE

Transcutaneous Electrical Nerve Stimulation (TENS) with the Compex SP8.0 device

Transcutaneous Electrical Nerve Stimulation (TENS) with the Compex SP8.0 device, using the following pain management program, • High Intensity TENS (50-150 Hz)

DEVICE

Transcutaneous Electrical Nerve Stimulation (TENS) with the Compex SP8.0 device

Transcutaneous Electrical Nerve Stimulation (TENS) with the Compex SP8.0 device, using the following pain management program, • Low Intensity TENS (5 Hz)

Sponsors & Collaborators

  • DJO UK Ltd

    lead INDUSTRY

Principal Investigators

  • Timothy Pigott · Salford University Sports Injury Clinic

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-28
Primary Completion
2025-09-30
Completion
2025-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06717789 on ClinicalTrials.gov